Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Chemed Corporation    CHE

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CHEMED CORPORATION : ex-dividend day

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 CET

A dividend is removed today from Chemed Corporation's share.



© Factset 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CHEMED CORPORATION
11/10 CHEMED CORPORATION : ex-dividend day
11/03 CHEMED CORPORATION : Declares Quarterly Dividend of 28 Cents
11/03 CHEMED CORPORATION (NYSE : CHE) Files An 8-K Entry into a Material Definitive Ag..
11/02 CHEMED CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosu..
10/31 CHEMED : Settles DOJ Litigation
10/31 CHEMED : and Vitas Hospice Services Agree to Pay $75 Million to Resolve False Cl..
10/30 CHEMED : and Vitas Hospice Services Agree to Pay $75 Million to Resolve False Cl..
10/27 CHEMED : Management's Discussion and Analysis of Financial Condition and Results..
10/27 CHEMED CORPORATION : to Host Earnings Call
10/27 CHEMED : posts 3Q profit
More news
News from SeekingAlpha
11/03 Chemed declares $0.28 dividend
10/31 Chemed settles DOJ civil case for $85M
10/27 Chemed Corporation (CHE) CEO Kevin McNamara Q3 2017 Results - Earnings Call T..
10/26 Chemed beats by $0.14, beats on revenue
10/25 Notable earnings after Thursday?s close
Financials ($)
Sales 2017 1 663 M
EBIT 2017 174 M
Net income 2017 98,3 M
Debt 2017 68,8 M
Yield 2017 0,47%
P/E ratio 2017 48,91
P/E ratio 2018 27,37
EV / Sales 2017 2,27x
EV / Sales 2018 2,14x
Capitalization 3 698 M
Chart CHEMED CORPORATION
Duration : Period :
Chemed Corporation Technical Analysis Chart | CHE | US16359R1032 | 4-Traders
Technical analysis trends CHEMED CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 229 $
Spread / Average Target -1,3%
EPS Revisions
Managers
NameTitle
Kevin J. McNamara President, Chief Executive Officer & Director
George J. Walsh Chairman
David Patrick Williams Chief Financial Officer & Executive Vice President
Joel F. Gemunder Independent Director
Thomas C. Hutton Director & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CHEMED CORPORATION45.30%3 698
FRESENIUS MEDICAL CARE2.97%29 952
HCA HEALTHCARE INC1.65%26 953
LABORATORY CORP. OF AMERICA HOLDINGS17.12%15 438
QUEST DIAGNOSTICS INC1.24%12 595
DAVITA INC-14.47%10 470